Please login to the form below

Not currently logged in
Email:
Password:

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions

EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions

as ‘point-of-care’ tests, to detect and characterise a variety of diseases within minutes.

Latest news

More from news
Approximately 20 fully matching, plus 296 partially matching documents found.

Latest Intelligence

  • Rare diseases: not so rare after all Rare diseases: not so rare after all

    New approaches. Historically, the small case numbers of rare diseases have led to their neglect. ... With recent advances, the range of disease areas has expanded and now includes very different indications, ranging from ophthalmology to infectious

  • The challenges of identifying rare diseases The challenges of identifying rare diseases

    Several factors contribute to the difficulty of accurately identifying and counting rare diseases. ... After excluding rare cancers, infectious diseases and poisonings, this study estimated that 262.9 to 446.2 million people worldwide are affected by a

  • Future-proofing pharma supply chains by improving inefficiencies in global health architecture Future-proofing pharma supply chains by improving inefficiencies in global health architecture

    But this has come at the expense of efforts to address other emerging infectious diseases (EIDs), including the running of clinical trials. ... Recent evidence for this growing support includes GSK’s announcement of a £1bn investment over ten years to

  • The fight against antimicrobial resistance The fight against antimicrobial resistance

    Several common respiratory diseases, including Streptococcus pneumoniae and Haemophilus influenzae, show reduced susceptibility to several classes of antibiotics. ... we are to avoid a surge of untreatable infectious diseases.

  • Paving the way for representation in clinical trials Paving the way for representation in clinical trials

    EM-90081 March 2022. Lee-Ann Farrell is Vaccines Lead and Dr Mohamed Lockhat is Medical Director, Infectious Diseases and Vaccines, both at Janssen UK. . ... Lee-Ann Farrell is Vaccines Lead and Dr Mohamed Lockhat is Medical Director, Infectious Diseases

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 13 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....